KIMS Acquires Stake in Sangli’s Ushahkal Abhinav Hospital

Transaction Value: Rs 15 Crore
Target Capacity: 316 Beds

Reader Takeaway: KIMS is expanding its regional footprint through a new strategic investment, though the target remains loss-making.

What just happened

Krishna Institute of Medical Sciences Ltd (KIMS) has signed definitive agreements to acquire a 5.82% equity stake in Ushahkal Abhinav Specialty Hospital LLP. The deal involves an aggregate cash consideration of Rs 15 crore, which was executed through a primary capital infusion. The company clarified that this acquisition is not a related party transaction and did not require specific regulatory approvals.

Why this matters

This investment aligns with KIMS’s broader strategy of inorganic growth. By securing a stake in an established quaternary care facility in Sangli, Maharashtra, KIMS is reinforcing its presence in tier-2 healthcare markets. Ushahkal Abhinav Specialty Hospital, founded in 2022, currently operates 316 beds with the infrastructure capacity to scale up to 500 beds.

Financial Context

The target facility reported a turnover of Rs 80.42 crore for FY26, up from Rs 73.55 crore in FY25 and Rs 64.51 crore in FY24. However, the entity reported a Profit After Tax (PAT) of -Rs 23.59 crore in FY26. Shareholders should watch how KIMS leverages its operational expertise to improve the target's profitability and navigate the current loss-making cycle.

What to track next

Investors should monitor future updates regarding the integration of the Sangli facility and any subsequent management or operational changes at Ushahkal Abhinav Specialty Hospital as KIMS seeks to optimize the asset's potential.